Hymenoxin
Hymenoxin (compound 7) is a dual inhibitor of iNOS and NF-κB with IC50 of 42.7 μM and 85.5 μM respectively. Hymenoxin can inhibit 16% of oxidative stress at a concentration of 125 μg/mL[1].
Product Specifications
CAS Number
[56003-01-1]
UNSPSC
12352005
Target
NF-κB; NO Synthase
Type
Natural Products
Related Pathways
Immunology/Inflammation; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/hymenoxin.html
Purity
95.0
Solubility
10 mM in DMSO
Smiles
O=C1C=C(C2=CC(OC)=C(OC)C=C2)OC3=C1C(O)=C(OC)C(O)=C3OC
Molecular Formula
C19H18O8
Molecular Weight
374.34
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N12735/Hymenoxin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N12735/Hymenoxin-SDS-MedChemExpress.pdf
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Phospho-MLKL (Ser345) Recombinant Antibody, AbBy Fluor™ 647 Conjugated
Recombinant Hyphomonas neptunium 7-cyano-7-deazaguanine synthase (queC)
Recombinant Hyphomonas neptunium 7-cyano-7-deazaguanine synthase (queC)